TXA6101 Chemical Structure, gram-negative FtsZ inhibitor - TAXIS Pharmaceuticals, Monmouth Junction, NJ

gram-negative FtsZ inhibitor

In vitro efficacy against E. coli

Literature starting point and opt

J. Antibiot

TAXIS Pharmaceuticals, Monmouth Junction, NJ

Context. TXA6101 (TAXIS Pharmaceuticals) is a filamentous temperature-sensitive mutant Z (FtsZ) protein inhibitor being developed for targeting gram-negative bacteria. Drug resistance continues to be a paramount challenge in antibiotic…

 this content is exclusive to
Premium members

Upgrade to a Premium Drug Hunter membership to unlock the full content and start reading now.